Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fabio Turco, Silke Gillessen, Richard Cathomas, Consuelo Buttigliero & Ursula Maria Vogl. (2022) Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs. Research and Reports in Urology 14, pages 339-350.
Read now
Read now
Sugunadevi Sakkiah, Hui Wen Ng, Weida Tong & Huixiao Hong. (2016) Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery. Expert Opinion on Therapeutic Targets 20:10, pages 1267-1282.
Read now
Read now
Álvaro Pinto. (2014) Beyond abiraterone. Cancer Biology & Therapy 15:2, pages 149-155.
Read now
Read now
Rahul R Deshmukh, Sara M Schmitt, Clara Hwang & Qing Ping Dou. (2014) Chemotherapeutic inhibitors in the treatment of prostate cancer. Expert Opinion on Pharmacotherapy 15:1, pages 11-22.
Read now
Read now
Articles from other publishers (2)
Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Gaurav Goyal, Heloisa Soares, Anthony Neuger, Domenico Copolla, Jongphil Kim & Richard Kim. (2018) Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer. Investigational New Drugs 37:3, pages 473-481.
Crossref
Crossref
Shalini Singh Yadav, Jinyi Li, Jennifer A. Stockert, James O’Connor, Bryan Herzog, Cordelia Elaiho, Matthew D. Galsky, Ashutosh Kumar Tewari & Kamlesh Kumar Yadav. (2016) Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer. Oncotarget 7:46, pages 76181-76196.
Crossref
Crossref